The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, fund raising and ...

Analysis of the TROPION-Breast01 study showed that treatment with Dato-DXd did not significantly improve overall survival compared with chemotherapy in HR-positive, HER2-low or -negative breast cancer ...

Here's what to know about FluMist, the upcoming DIY flu vaccine. FluMist won't be available until next year, according to the ...

This summary provides key updates in the health sector, including AstraZeneca's unsuccessful breast cancer trial, bird flu ...